Celldex Therapeutics Inc. (CLDX)
NASDAQ: CLDX
· Real-Time Price · USD
25.44
0.50 (2.00%)
At close: Aug 15, 2025, 2:57 PM
Celldex Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 730K | 695K | 1.18M | 3.19M | 2.5M | 156K | 4.13M | 1.52M | 268K | 967K | 1.61M | 407K | 163K | 174K | 333K | 153K | 3.48M | 685K |
Cost of Revenue | n/a | n/a | 819K | 786K | 797K | 775K | 759K | 767K | 756K | 726K | 673K | 21.57M | 741K | 17.06M | 14.68M | 13.56M | 12.36M | 12.72M |
Gross Profit | 730K | 695K | 356K | 3.19M | 1.7M | -619K | 3.37M | 750K | -488K | 241K | 940K | -21.16M | -578K | -16.88M | -14.35M | -13.4M | -8.88M | -12.04M |
Operating Income | -63.86M | -62.74M | -56.03M | -52.13M | -46.32M | -40.61M | -47.63M | -41.24M | -33.2M | -32.47M | -27.89M | -27.7M | -36.4M | -23.26M | -20.34M | -20.82M | -13.44M | -16.64M |
Interest Income | 7.26M | 8.94M | 8.94M | 10.01M | 10.47M | 7.8M | 4.32M | 2.98M | 2.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -56.6M | -53.8M | -47.09M | -42.12M | -35.84M | -32.81M | -43.31M | -38.26M | -30.5M | -29.36M | -26.49M | -26.78M | -36M | -23.05M | -20.15M | -20.68M | -13.37M | -16.54M |
Net Income | -56.6M | -53.8M | -47.09M | -42.12M | -35.84M | -32.81M | -43.31M | -38.26M | -30.5M | -22.41M | -23.69M | -26.78M | -52.57M | -21.56M | -20.15M | -20.45M | -13.37M | -16.54M |
Selling & General & Admin | 10.39M | 10.82M | 10.26M | 10.05M | 9.13M | 9.1M | 8.83M | 8.22M | 7.22M | 6.64M | 6.6M | 6.53M | 7.15M | 6.91M | 6.24M | 5.82M | 4.31M | 4.12M |
Research & Development | 54.2M | 52.61M | 46.12M | 3K | 38.89M | 30.89M | 29.67M | 34.53M | 26.25M | 26.8M | 22.9M | 21.57M | 20.73M | 17.06M | 14.68M | 13.56M | 12.36M | 12.72M |
Other Expenses | n/a | n/a | n/a | 45.26M | n/a | n/a | n/a | -767K | 26.24M | n/a | n/a | n/a | 8.67M | 16.49M | n/a | 1.6M | 12.59M | 13.2M |
Operating Expenses | 64.59M | 63.43M | 56.38M | 55.32M | 48.02M | 39.99M | 38.5M | 41.99M | 33.47M | 33.44M | 29.5M | 28.1M | 27.89M | 23.97M | 20.92M | 19.38M | 16.66M | 16.84M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 3.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.91M | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 64.59M | 63.43M | 57.2M | 55.32M | 48.81M | 40.76M | 51.76M | 42.76M | 33.47M | 33.44M | 29.5M | 28.1M | 27.89M | 23.97M | 20.92M | 19.38M | 16.66M | 16.84M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.95M | -2.8M | n/a | 16.56M | -1.49M | n/a | -227K | n/a | n/a |
Shares Outstanding (Basic) | 66.39M | 66.38M | 66.35M | 66.29M | 66.02M | 58.87M | 52.03M | 47.26M | 47.25M | 47.21M | 47.13M | 46.92M | 46.76M | 46.74M | 46.58M | 45.45M | 39.33M | 39.38M |
Shares Outstanding (Diluted) | 66.39M | 66.38M | 66.35M | 66.29M | 66.02M | 58.87M | 52.03M | 47.26M | 47.25M | 47.21M | 47.13M | 46.92M | 46.76M | 46.74M | 46.69M | 45.45M | 39.62M | 39.61M |
EPS (Basic) | -0.85 | -0.81 | -0.71 | -0.64 | -0.54 | -0.56 | -0.83 | -0.81 | -0.65 | -0.47 | -0.5 | -0.57 | -1.12 | -0.46 | -0.43 | -0.45 | -0.34 | -0.42 |
EPS (Diluted) | -0.85 | -0.81 | -0.71 | -0.64 | -0.54 | -0.56 | -0.83 | -0.81 | -0.65 | -0.47 | -0.5 | -0.57 | -1.12 | -0.46 | -0.43 | -0.45 | -0.34 | -0.42 |
EBITDA | -62.98M | -61.87M | -55.21M | -51.34M | -45.52M | -39.83M | -34.37M | -40.47M | -32.45M | -31.75M | -27.21M | -27.02M | -26.98M | -22.98M | -19.81M | -18.47M | -12.42M | -15.38M |
EBIT | -63.86M | -62.74M | -56.03M | -52.13M | -46.32M | -40.61M | -35.13M | -41.24M | -33.2M | -32.47M | -27.89M | -27.7M | -27.72M | -23.79M | -20.59M | -19.23M | -13.18M | -16.16M |
Depreciation & Amortization | 873K | 867K | 819K | 786K | 797K | 775K | 759K | 767K | 756K | 726K | 673K | 671K | 741K | 811K | 777K | 752K | 764K | 775K |